Dr Lal Pathlabs Ratios

Dr Lal Pathlabs Ltd Ratios

The Dr Lal Pathlabs Ltd Ratios page provides a complete fundamental analysis of Dr Lal Pathlabs Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Dr Lal Pathlabs Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Dr Lal Pathlabs Ltd (NSE: LALPATHLAB, BSE: 539524) is currently trading at ₹1367.20, with a market capitalization of ₹234.16B. As a major player in the Health services sector and Medical/Nursing services industry, Dr Lal Pathlabs Ltd remains a key stock for fundamental analysis using Dr Lal Pathlabs Ltd Ratios.

Dr Lal Pathlabs Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Dr Lal Pathlabs Ltd P/E ratio currently stands at 42.44, making it one of the most tracked metrics in Dr Lal Pathlabs Ltd Ratios.

Historically, the Dr Lal Pathlabs Ltd P/E ratio has shown strong fluctuations:

• 2024: 42.44
• 2023: 52.65
• 2022: 63.61
• 2021: 62.71
• 2020: 76.82

The decline in Dr Lal Pathlabs Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Dr Lal Pathlabs Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 9.51.

Historical P/B trend:

• 2024: 9.51
• 2023: 10.18
• 2022: 9.09
• 2021: 14.36

Dr Lal Pathlabs Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Dr Lal Pathlabs Ltd P/S ratio currently stands at 8.40, an important part of Dr Lal Pathlabs Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 8.40
• 2023: 8.46
• 2022: 7.53
• 2021: 10.36

A stable or declining Dr Lal Pathlabs Ltd P/S ratio indicates cautious market sentiment.

Dr Lal Pathlabs Ltd Price to Cash Flow Ratio (P/CF)

The Dr Lal Pathlabs Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 32.87.

Historical Dr Lal Pathlabs Ltd Price to Cash Flow Ratio:

• 2024: 32.87
• 2023: 32.96
• 2022: 32.24
• 2021: 44.51
• 2020: 51.21

The declining Dr Lal Pathlabs Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Dr Lal Pathlabs Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Dr Lal Pathlabs Ltd EV currently stands at ₹196.98B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 196.98B
• 2023: 181.72B
• 2022: 148.31B
• 2021: 215.1B

Dr Lal Pathlabs Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Dr Lal Pathlabs Ltd EV/EBITDA ratio is currently 27.83, a key metric in Dr Lal Pathlabs Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 27.83
• 2023: 29.33
• 2022: 29.76
• 2021: 37.73

Stable Dr Lal Pathlabs Ltd EV/EBITDA indicates balanced valuation.

Dr Lal Pathlabs Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Dr Lal Pathlabs Ltd D/E ratio is currently 0.07, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.07
• 2023: 0.13
• 2022: 0.25
• 2021: 0.35

Dr Lal Pathlabs Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Dr Lal Pathlabs Ltd ROE currently stands at 24.22%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 24.22
• 2023: 20.35
• 2022: 15.05
• 2021: 25.11

Dr Lal Pathlabs Ltd demonstrates strong profitability and efficient capital utilization.

Dr Lal Pathlabs Ltd Ratios Analysis Summary

The Dr Lal Pathlabs Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Dr Lal Pathlabs Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Dr Lal Pathlabs Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.